Novo Nordisk Expands Cardio Push with German Buy
Wall Street Journal
Novo Nordisk is buying Cardior Pharmaceuticals for around $1 billion as the Wegovy maker moves to strengthen its pipeline of drugs to treat cardiovascular disease and expand into areas outside of its core diabetes and weight-loss market.